| Literature DB >> 35056835 |
Amal Adnan Ashour1, Sakeenabi Basha2, Nayef H Felemban3, Enas T Enan4, Amal Ahmed Alyamani5, Sanaa M F Gad El-Rab6.
Abstract
In the present study, Zingiber officinale is used for the synthesis of Zingiber officinale capped silver nanoparticles (ZOE-AgNPs) and compares the antimicrobial efficacy and compressive strength of conventional glass ionomer cement (GIC) combined with ZOE-AgNPs, lyophilized miswak, and chlorhexidine diacetate (CHX) against oral microbes. Five groups of the disc-shaped GIC specimens were prepared. Group A: lyophilized miswak and GIC combination, Group B: ZOE-AgNPs and GIC combinations, Group C: CHX and GIC combination, Group D: ZOE-AgNPs + CHX + GIC; Group E: Conventional GIC. Results confirmed the successful formation of ZOE-AgNPs that was monitored by UV-Vis sharp absorption spectra at 415 nm. The X-ray diffractometer (XRD) and transmission electron microscope (TEM) results revealed the formation of ZOE-AgNPs with a mean size 10.5-14.12 nm. The peaks of the Fourier transform infrared spectroscopy (FTIR) were appearing the involvement of ZOE components onto the surface of ZOE-AgNPs which played as bioreducing, and stabilizing agents. At a 24-h, one-week and three-week intervals, Group D showed the significantly highest mean inhibitory zones compared to Group A, Group B, and Group C. At microbe-level comparison, Streptococcus mutans and Staphylococcus aureus were inhibited significantly by all the specimens tested except group E when compared to Candida albicans. Group D specimens showed slightly higher (45.8 ± 5.4) mean compressive strength in comparison with other groups. The combination of GIC with ZOE-AgNPs and chlorhexidine together enhanced its antimicrobial efficacy and compressive strength compared to GIC with ZOE-AgNPs or lyophilized miswak or chlorhexidine combination alone. The present study revealed that The combination of GIC with active components of ZOE-AgNPs and chlorhexidine paves the way to lead its effective nano-dental materials applications.Entities:
Keywords: GIC; ZOE-AgNPs; antimicrobial efficacy; chlorhexidine; miswak
Mesh:
Substances:
Year: 2022 PMID: 35056835 PMCID: PMC8781574 DOI: 10.3390/molecules27020528
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Schema of synthetic diagram for ZOE-AgNPs/CHX/GIC and their synergistic antimicrobial efficacy.
Figure 1UV-Vis spectral range showing a peak of ZOE-AgNPs at 415 nm.
Figure 2TEM image ZOE-AgNPs.
Figure 3XRD pattern of AgNPs.
Figure 4FT-IR spectra of AgNPs synthesized with ZOE.
Antimicrobial efficacy of tested GIC specimens at different time intervals.
| Study Groups with Tested Microbes | Inhibition Zone in mm | ||
|---|---|---|---|
| InZ | InZ | InZ | |
|
| |||
| a- Group A (n = 30) | 16.3 ± 2.1 | 12.4 ± 1.1 | 9.4 ± 1.1 |
| b- Group B (n = 30) | 21.3 ± 1.4 | 15.6 ± 1.2 | 13.3 ± 1.1 |
| c- Group C (n = 30) | 19.8 ± 1.9 | 15.3 ± 1.2 | 13.2 ± 1.1 |
| d- Group D (n = 30) | 25.2 ± 2.2 | 21.2 ± 1.8 | 18.3 ± 1.3 |
| e- Group E (n = 30) | 10.5 ± 1.6 | 0 | 0 |
| ANOVA, F value | 16.712 | 7.172 | 6.341 |
| ANOVA, | 0.0001 | 0.003 | 0.03 |
| Tukey post Hoc | d > e, d > a, d > c, d > b, b > e, b > a, c > e, a > e | d > a, d > c, d > b | d > a, d > b, d >c |
|
| |||
| a- Group A (n = 30) | 18.1 ± 1.9 | 12.2 ± 1.2 | 9.3 ± 1.1 |
| b- Group B (n = 30) | 19.4 ± 2.1 | 14.4 ± 1.1 | 12.1 ± 0.9 |
| c- Group C (n = 30) | 20.7 ± 1.5 | 16.4 ± 1.6 | 14.4 ± 1.5 |
| d- Group D (n = 30) | 26.2 ± 2.6 | 22.2 ± 2.1 | 19.1 ± 1.7 |
| e- Group E (n = 30) | 9.2 ± 1.2 | 0 | 0 |
| ANOVA, F value | 17.821 | 5.328 | 6.723 |
| ANOVA, | 0.0001 | 0.04 | 0.03 |
| Tukey post Hoc | d > e, d > a, d > c, d > b, b > e, c > e, a > e | d > a, d > b, d > c, c > a | d > a, d > b, d >c, b > a, c > a |
|
| |||
| a- Group A (n = 30) | 15.3 ± 1.1 | 10.2 ± 1.2 | 8.6 ± 0.9 |
| b- Group B (n = 30) | 16.3 ± 1.1 | 11.2 ± 1.5 | 9.2 ± 1.3 |
| c- Group C (n = 30) | 17.2 ± 1.2 | 13.4 ± 1.3 | 10.8 ± 1.1 |
| d- Group D (n = 30) | 20.4 ± 2.1 | 18.2 ± 1.9 | 16.3 ± 1.3 |
| e- Group E (n = 30) | 2.3 ± 1.1 | 0 | 0 |
| ANOVA, F value | 14.231 | 6.421 | 6.723 |
| ANOVA, | 0.0001 | 0.03 | 0.03 |
| Tukey post Hoc | d > e, d > a, d > c, d > b, b > e, c > e, a > e | d > a, d > b, d > c, c > a | d > a, d > b, d >c, c > a |
Group A—GIC + lyophilized miswak, Group B—GIC + ZOE-AgNPs, Group C—GIC + chlorhexidine diacetate, Group D—GIC + ZOE-AgNPs + Chlorhexidine, Group E—control (glass ionomer alone), InZ—inhibition zone, h—hour, n(a–e)—Number of speciment.
Figure 5Antimicrobial efficacy of tested GIC specimens at different time intervals. GIC—Glass ionomer cement, Group A—GIC + lyophilized miswak, Group B—GIC + ZOE-AgNPS, Group C—GIC + chlorhexidine diacetate, Group D—GIC + ZOE-AgNPs + Chlorhexidine, Group E—control (glass ionomer alone).
Comparison of earlier research with restorative materials for antibacterial activity against oral bacteria.
| Materials | Concentration | Bacteria | Reference |
|---|---|---|---|
|
GIC + CHX |
99.5% GIC + 0.5% CHX |
|
Kabil et al. [ |
|
GIC + AgNPs |
99.5% GIC + 0.5% AgNPs |
|
Paiva et al. [ |
|
GIC + miswak |
GIC + 1.25% miswak |
|
Shahriari et al. [ |
|
AgNPs + CHX Solution |
15 µg/mL AgNPs + 2% CHX |
|
Charannya et al. [ |
|
GIC + ZOE-AgNPs + CHX |
98.5% GIC + 0.5% ZOE-AgNPs + 1% CHX |
|
This study |
Compressive strength (MPa) of tested specimens.
| Study Groups | n | Mean ± SD | ANOVA F Value | ANOVA |
|---|---|---|---|---|
| Group A | 10 | 43.2 ± 3.1 | 2.326 | 0.07 |
| Group B | 10 | 44.7 ± 4.8 | ||
| Group C | 10 | 43.9 ± 3.6 | ||
| Group D | 10 | 45.8 ± 5.4 | ||
| Group E | 10 | 42.4 ± 2.7 |
Group A—GIC + lyophilized miswak, Group B—GIC + ZOE-AgNPs, Group C—GIC + chlorhexidine diacetate, Group D—GIC + ZOE-AgNPs + Chlorhexidine, Group E—control (glass ionomer alone), SD—standard deviation, ANOVA—analysis of variance.
Proportion of the Lyophilized miswak, ZOE-AgNPs and Chlorhexidine diacetate added to Conventional GIC.
| Group | Abbreviation | Components |
|---|---|---|
| Group A |
Lyophilized miswak/GIC |
(99% GIC with 1% lyophilized miswak, |
| Group B |
ZOE-AgNPs/GIC |
(99.5% GIC with 0.5% ZOE-AgNPs, |
| Group C |
CHX/GIC |
(99% GIC with 1% CHX, w/ |
| Group D |
CHX/ZOE-AgNPs/GIC |
(98% GIC with 1% CHX, 0.5% ZOE-AgNPs ( |
| Group E |
GIC |
Conventional GIC without any addition. |